The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ANIX's RSI Oscillator exited the oversold zone, 19 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
Following a +5.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIX advanced for three days, in 180 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
ANIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIX as a result. In 91 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for ANIX turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 41 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for ANIX entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. ANIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.438) is normal, around the industry mean (2.978). P/E Ratio (-8.375) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (384.615) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The 10-day moving average for RCKT crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCKT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for RCKT entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RCKT's RSI Oscillator exited the oversold zone, 33 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for RCKT just turned positive on October 20, 2026. Looking at past instances where RCKT's MACD turned positive, the stock continued to rise in 45 of 52 cases over the following month. The odds of a continued upward trend are 87%.
Following a +7.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCKT advanced for three days, in 204 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
RCKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.696) is normal, around the industry mean (3.009). P/E Ratio (-14.625) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. RCKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ANIX | RCKT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 87 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 92 | |
PRICE GROWTH RATING 1..100 | 50 | 87 | |
P/E GROWTH RATING 1..100 | 16 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RCKT's Valuation (11) in the Biotechnology industry is somewhat better than the same rating for ANIX (69) in the Computer Peripherals industry. This means that RCKT’s stock grew somewhat faster than ANIX’s over the last 12 months.
RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that RCKT’s stock grew similarly to ANIX’s over the last 12 months.
RCKT's SMR Rating (92) in the Biotechnology industry is in the same range as ANIX (98) in the Computer Peripherals industry. This means that RCKT’s stock grew similarly to ANIX’s over the last 12 months.
ANIX's Price Growth Rating (50) in the Computer Peripherals industry is somewhat better than the same rating for RCKT (87) in the Biotechnology industry. This means that ANIX’s stock grew somewhat faster than RCKT’s over the last 12 months.
RCKT's P/E Growth Rating (15) in the Biotechnology industry is in the same range as ANIX (16) in the Computer Peripherals industry. This means that RCKT’s stock grew similarly to ANIX’s over the last 12 months.
| ANIX | RCKT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 1 day ago 80% |
| Stochastic ODDS (%) | 2 days ago 87% | 1 day ago 76% |
| Momentum ODDS (%) | 2 days ago 88% | N/A |
| MACD ODDS (%) | 2 days ago 85% | 1 day ago 87% |
| TrendWeek ODDS (%) | 2 days ago 84% | 1 day ago 80% |
| TrendMonth ODDS (%) | 2 days ago 82% | 1 day ago 84% |
| Advances ODDS (%) | 21 days ago 81% | 1 day ago 80% |
| Declines ODDS (%) | 2 days ago 82% | 7 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 86% | 1 day ago 80% |
| Aroon ODDS (%) | 2 days ago 82% | 1 day ago 82% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANIX’s FA Score shows that 1 FA rating(s) are green while RCKT’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANIX’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).
ANIX (@Biotechnology) experienced а +0.37% price change this week, while RCKT (@Biotechnology) price change was +1.74% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.
ANIX is expected to report earnings on Jan 06, 2027.
RCKT is expected to report earnings on Nov 05, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ILOW | 46.17 | 0.38 | +0.83% |
| AB Active ETFs Inc. | |||
| BTR | 25.59 | N/A | N/A |
| Beacon Tactical Risk ETF (BTR) | |||
| SBI | 7.27 | -0.02 | -0.27% |
| Western Asset Intermediate Muni Fund | |||
| PLTY | 35.74 | -0.17 | -0.47% |
| YieldMax PLTR Option Income Strategy ETF | |||
| RXD | 13.08 | -0.62 | -4.52% |
| ProShares UltraShort Health Care (RXD) | |||
A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with PRME. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then PRME could also see price increases.
| Ticker / NAME | Correlation To ANIX | 1D Price Change % | ||
|---|---|---|---|---|
| ANIX | 100% | +2.68% | ||
| PRME - ANIX | 43% Loosely correlated | +2.35% | ||
| TNYA - ANIX | 42% Loosely correlated | +8.58% | ||
| RXRX - ANIX | 41% Loosely correlated | +1.39% | ||
| RCKT - ANIX | 40% Loosely correlated | +4.46% | ||
| CRSP - ANIX | 39% Loosely correlated | -0.32% | ||
More | ||||